Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 underlie a congenital myasthenic syndrome (CMS) associated with small and simplified neuromuscular synapses likely due to impaired...
Hlavní autoři: | Hamuro, J, Higuchi, O, Okada, K, Ueno, M, Iemura, S, Natsume, T, Spearman, H, Beeson, D, Yamanashi, Y |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
Autor: Cossins, J, a další
Vydáno: (2025) -
Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
Autor: Palace, J
Vydáno: (2010) -
Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Autor: Yamanashi, Y, a další
Vydáno: (2008) -
EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
Autor: Lashley, D, a další
Vydáno: (2009) -
Dok-7 mutations underlie a neuromuscular junction synaptopathy.
Autor: Beeson, D, a další
Vydáno: (2006)